碰撞瘤:我们最近的经验
Adam Zalewski1, Iwona Chlebicka1, Jacek C Szepietowski1
1Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland.
Postepy dermatologii i alergologii
|January 29, 2025
概括
碰撞皮肤病变 (CSLs) 很少见,并且难以诊断. 这项研究确定了4个病例,突出了通过皮肤镜检测提高认识和早期发现的必要性,以有效管理.
科学领域:
- 皮肤病学 皮肤病学
- 病理学 病理学 病理学
- 手术瘤学手术瘤学
背景情况:
- 碰撞皮肤病变 (CSLs) 是一种罕见的实体,具有明显的良性和/或恶性瘤细胞群.
- 由于CSL的复杂性,CSL会带来诊断和治疗方面的挑战.
研究的目的:
- 分析和呈现手术治疗的碰撞皮肤病变病例.
- 为了解这些罕见瘤的管理做出贡献.
主要方法:
- 从2021-2022年开始在皮肤外科病房接受治疗的患者的回顾性评估.
- 排除因先前存在的疾病或同一部位可分离的病变引起的病变.
主要成果:
- 在838名患者中,发现了4例碰撞瘤,并通过组织学确认.
- 这些病例包括一个良性-良性碰撞瘤和三个良性-恶性碰撞瘤.
结论:
- 碰撞瘤存在诊断挑战,需要高度意识和早期检测,通常需要皮肤镜检查的帮助.
- 切除活检是一种有利的方法,优先考虑更具攻击性的瘤组成部分.
- 进一步的研究对于了解病原和优化治疗策略至关重要.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.